These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19426820)

  • 21. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP).
    Kremer JJ; Bills AJ; Hanke NJ; Chen H; Meier WA; Osinski MA; Foley CM
    J Pharmacol Toxicol Methods; 2015; 75():27-37. PubMed ID: 26001324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of respiratory function in freely moving Beagle dogs using implanted impedance technology.
    Kearney K; Metea M; Gleason T; Edwards T; Atterson P
    J Pharmacol Toxicol Methods; 2010; 62(2):119-26. PubMed ID: 20601021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous solid tip lead placement in telemetry implanted dogs. Part 1: Surgical methods, signal quality, and pathological endpoints.
    Walisser JA; Mitchell AZ; Bills AJ; Sharma AK; Latimer K; Taschwer M; Osinski MA
    J Pharmacol Toxicol Methods; 2013; 68(1):52-61. PubMed ID: 23608149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 1: Non-pharmacological validation.
    Authier S; Tanguay JF; Gauvin D; Di Fruscia R; Fournier S; Chaurand F; Troncy E
    J Pharmacol Toxicol Methods; 2007; 56(2):115-21. PubMed ID: 17587601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    Tattersall ML; Dymond M; Hammond T; Valentin JP
    J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpoints.
    Baird TJ; Bailie M; Patrick DJ; Moddrelle D; Yoder J; Gauvin DV; Dalton JA
    J Pharmacol Toxicol Methods; 2013; 67(3):148-61. PubMed ID: 23438450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
    Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
    J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.
    Sivarajah A; Collins S; Sutton MR; Regan N; West H; Holbrook M; Edmunds N
    J Pharmacol Toxicol Methods; 2010; 62(1):12-9. PubMed ID: 20570743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog.
    Taylor GL; Patel B; Sullivan AT
    J Pharmacol Toxicol Methods; 2007; 56(2):212-7. PubMed ID: 17582788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimisation and evaluation.
    Adeyemi O; Roberts S; Harris J; West H; Shome S; Dewhurst M
    J Pharmacol Toxicol Methods; 2009; 60(2):159-66. PubMed ID: 19616109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation.
    Authier S; Tanguay JF; Gauvin D; Fruscia RD; Troncy E
    J Pharmacol Toxicol Methods; 2007; 56(2):122-30. PubMed ID: 17587605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals.
    Henriques TA; Beck TW; Douglas CL; Jones HM; Kremer JJ; Kruzich PJ; Sarazan RD
    J Pharmacol Toxicol Methods; 2010; 62(2):136-42. PubMed ID: 20550968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
    Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
    J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving laboratory beagle dog by remote radiotelemetry.
    Gauvin DV; Tilley LP; Smith FW; Baird TJ
    J Pharmacol Toxicol Methods; 2006; 53(2):128-39. PubMed ID: 16380274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate-correction technique for QT interval in long-term telemetry ECG recording in beagle dogs.
    Miyazaki H; Tagawa M
    Exp Anim; 2002 Oct; 51(5):465-75. PubMed ID: 12451707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (mAb Fab-SEA/E) using telemetric monitoring in conscious rabbits.
    Ilbäck NG; Persson R; Gunnarsson K; Stålhandske T
    J Pharmacol Toxicol Methods; 2002; 48(1):31-9. PubMed ID: 12750039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple-to-use, reference criteria for revealing drug-induced QT interval prolongation in conscious dogs.
    Schmitt MW; Von Landenberg F; Poth H; Wimmer E; Goddemeier T; Cavero I
    Eur J Pharmacol; 2007 Jan; 554(1):46-52. PubMed ID: 17112506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.